全文获取类型
收费全文 | 654篇 |
免费 | 50篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 16篇 |
妇产科学 | 40篇 |
基础医学 | 113篇 |
口腔科学 | 10篇 |
临床医学 | 49篇 |
内科学 | 110篇 |
皮肤病学 | 4篇 |
神经病学 | 83篇 |
特种医学 | 1篇 |
外科学 | 31篇 |
综合类 | 51篇 |
预防医学 | 79篇 |
眼科学 | 8篇 |
药学 | 35篇 |
中国医学 | 4篇 |
肿瘤学 | 89篇 |
出版年
2024年 | 1篇 |
2023年 | 1篇 |
2022年 | 12篇 |
2021年 | 16篇 |
2020年 | 21篇 |
2019年 | 16篇 |
2018年 | 20篇 |
2017年 | 20篇 |
2016年 | 31篇 |
2015年 | 12篇 |
2014年 | 31篇 |
2013年 | 54篇 |
2012年 | 47篇 |
2011年 | 42篇 |
2010年 | 30篇 |
2009年 | 42篇 |
2008年 | 52篇 |
2007年 | 64篇 |
2006年 | 42篇 |
2005年 | 37篇 |
2004年 | 39篇 |
2003年 | 33篇 |
2002年 | 20篇 |
2001年 | 14篇 |
2000年 | 16篇 |
1999年 | 9篇 |
1997年 | 1篇 |
1996年 | 1篇 |
排序方式: 共有724条查询结果,搜索用时 15 毫秒
1.
2.
Parle-McDermott A Mills JL Kirke PN O'Leary VB Swanson DA Pangilinan F Conley M Molloy AM Cox C Scott JM Brody LC 《Journal of human genetics》2003,48(4):190-193
The thermolabile variant (677TT) of methylenetetrahydrofolate reductase (MTHFR) is a known risk factor for neural tube defects
(NTDs). The relationship between a second MTHFR polymorphism (1298A→C) and NTD risk has been inconsistent between studies.
We genotyped 276 complete NTD triads (mother, father and child affected with an NTD) and 256 controls for MTHFR 1298A→C. Our
findings do not support a role for the 1298A→C polymorphism in NTDs (OR 0.85 (95% CI 0.49–1.47), p= 0.55), nor do we observe a combined effect with the 677C→T polymorphism.
Electronic Publication 相似文献
3.
Richter B Stegmann K Röper B Böddeker I Ngo ET Koch MC 《Journal of human genetics》2001,46(3):105-109
Neural tube defects (NTD) are likely to result from an interaction of several genes and environmental factors. Because periconceptional
folate intake reduces the NTD risk in the fetus, and because mothers of children with NTD showed elevated plasma homocysteine
levels, gene polymorphisms of the folate and homocysteine pathway, such as 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T, MTHFR 1298A→C and cystathionine β-synthase (CBS) 844ins68, have been implicated in the etiology of NTD. Several studies have demonstrated that these polymorphisms may indeed
be associated with NTD in some populations. In order to evaluate the role of these polymorphisms and their interaction in
NTD, we genotyped 417 individuals for case-control studies and 129 families for transmission disequilibrium tests. We are
the first to present detailed data on MTHFR haploid genotypes in combination with CBS 844ins68. The MTHFR risk genotype 677CT/1298AC, known to be associated with decreased enzyme activity and increased homocysteine, was found significantly
more often in patients than in controls (P = 0.02). A CBS insertion allele in addition to MTHFR 677CT/1298AC heterozygosity or MTHFR 677TT/1298AA homozygosity did not result in an increased risk for NTD. This is in agreement with the recently reported homocysteine-lowering
effect of the CBS 844ins68 allele in carriers of MTHFR variants.
Received: August 28, 2000 / Accepted: December 4, 2000 相似文献
4.
Around 6% of infants born to mothers taking anticonvulsants have malformations, including neural tube defects, and a further proportion show developmental delay in later childhood. Three commonly used anticonvulsants, carbamazepine, phenytoin and sodium valproate, interfere with folic acid metabolism. We investigated the common 677 C>T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in samples from 57 patients and their parents and 152 controls to determine its contribution to the risk of fetal anticonvulsant syndrome. The 677 C>T mutation frequency was significantly higher in the mothers than in the controls, but there was no significant difference in 677 C>T frequency in the patients or in the fathers. Genotype frequencies in the mothers were significantly different from controls, there being an excess of 677 C>T homozygotes. Amongst the patients, there was an apparent excess of heterozygotes (not statistically significant), and the fathers were not significantly different from controls. Mutation in the MTHFR gene in a mother taking sodium valproate, phenytoin or carbamazepine during pregnancy is associated with fetal anticonvulsant syndrome in her offspring. The skewed distribution of genotypes in the affected children probably reflects the association of fetal anticonvulsant syndrome with the maternal genotype. 相似文献
5.
An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis 总被引:3,自引:0,他引:3
Kawamoto R Kohara K Tabara Y Miki T Doi T Tokunaga H Konishi I 《Journal of human genetics》2001,46(9):506-510
Plasma homocysteine (Hcy) concentration has been shown to be influenced by a mutation in the gene coding methylenetetrahydrofolate
reductase (MTHFR). Although plasma Hcy is related to atherosclerotic disorders, conflicting results have been reported about
the association between MTHFR gene polymorphism and sclerotic lesions of the common carotid arteries. The effect of age–gene interaction on carotid arterial
remodeling was investigated in elderly subjects with several risk factors for atherosclerosis. We evaluated sclerotic lesions
of the common carotid arteries by ultrasonography in 326 patients (mean age ± standard deviation, 73 ± 12 years) and studied
relations among the known risk factors for atherosclerosis, including MTHFR gene polymorphism and its interactions with age and sex. Of the 326 subjects studied, 136 had MTHFR genotype CC, 136 genotype CT, and 54 genotype TT. The three groups did not differ with respect to background factors such as age, history of cigarette smoking, blood pressure,
lipids or uric acid, or in the incidence of atherosclerotic diseases. Spearman's rank correlation revealed a significant relationship
between gender, age, Brinkman index, systolic blood pressure, triglycerides, HDL-cholesterol (HDL-C), uric acid, and MTHFR gene polymorphism. Multiple regression analysis using intima-media complex thickness (IMT) as a criterion variable and risk
factors, including MTHFR gene polymorphism as explanatory variables showed that MTHFR gene polymorphism (P = 0.039) was a significant independent explanatory variable for IMT, along with gender (male) (P < 0.001), age (P < 0.001), systolic blood pressure (SBP) (P = 0.047), total cholesterol (T-C) (P < 0.001), and HDL-C (P < 0.001). Furthermore, a general linear model analysis revealed that interaction between age and MTHFR gene polymorphism was significantly associated with IMT, independently of age, SBP, T-C, and HDL-C in male subjects. However,
age–gene interaction was not observed in female subjects. The findings of the present study confirm an association between
MTHFR gene polymorphism and common carotid atherosclerosis in the Japanese population and further support the role of risk factor–gene
interaction in common carotid atherosclerosis.
Received: May 14, 2001 / Accepted: June 8, 2001 相似文献
6.
〔摘要〕 妊娠高血压综合征(妊高征)产科常见的并发症,是引起孕产妇和围产儿死亡的主要原因之一,对其发病原因和机理尚不清楚。一般认为是由环境因素和遗传因素共同作用造成的,目前的研究热点是易感基因与妊高征的关系。本文对内皮型一氧化氮合酶(eNOS)基因和亚甲基四氢叶酸还原酶(MTHFR)基因多态性与妊高征发病的相关性进行了综述。 相似文献
7.
Montgomery GW Zhao ZZ Morley KI Marsh AJ Boomsma DI Martin NG Duffy DL 《Human reproduction (Oxford, England)》2003,18(11):2460-2464
BACKGROUND: Folate metabolism is critical to embryonic development, influencing neural tube defects (NTD) and recurrent early pregnancy loss. Polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR) have been associated with dizygotic (DZ) twinning through pregnancy loss. METHODS: The C677T and A1298C polymorphisms in MTHFR were genotyped in 258 Australasian families (1016 individuals) and 118 Dutch families (462 individuals) of mothers of DZ twins and a population sample of 462 adolescent twin families (1861 individuals). Haplotypes were constructed from the alleles, and transmission of the MTHFR haplotypes to mothers of DZ twins and from parents to twins in the adolescent twin families analysed. RESULTS: The C677T and A1298C were common in all three populations (frequencies > 0.29). There was strong linkage disequilibrium (D' = 1) between the variants, showing that specific combinations of alleles (haplotypes) were transmitted together. Three haplotypes accounted for nearly all the variation. There was no evidence of any association between MTHFR genotype and twinning in mothers of twins, or of the loss of specific MTHFR genotypes during twin pregnancies. CONCLUSIONS: It is concluded that variation in twinning frequency is not associated with MTHFR genotype. 相似文献
8.
Friso S Girelli D Trabetti E Stranieri C Olivieri O Tinazzi E Martinelli N Faccini G Pignatti PF Corrocher R 《Clinical and experimental medicine》2002,2(1):7-12
5, 10-Methylenetetrahydrofolate reductase (MTHFR) is a crucial enzyme in homocysteine/methionine metabolism. The most-studied C677T polymorphism in the MTHFR gene results in a thermolabile variant with reduced activity, and is associated with increased levels of total plasma homocysteine, a risk factor for coronary artery disease. A new mutation in the MTHFR gene (A1298C) has also been reported to lower enzyme activity. Whether A1298C is a risk factor for coronary artery disease, separately or in combination with C677T, and/or relative to total plasma homocysteine and folate status, is unclear to date. We evaluated this hypothesis in 470 angiographically characterized subjects, 302 with coronary artery disease, and 168 with normal coronary arteries. The frequency of the 1298C allele was 0.33 and that of combined heterozygosity 0.315. No difference was found in the frequency of the genotypes or when analyzed for combined heterozygosity between patients with coronary artery disease and normals. Independent of folate status, the 1298C allele was not associated with increased total plasma homocysteine. No additional effect of A1298C on total plasma homocysteine was observed in 148 combined heterozygotes compared with 98 heterozygotes for the C677T alone. These findings do not support a major role for the A1298C mutation in homocysteine metabolism and emphasize the hypothesis that MTHFR genotypes may interfere with coronary artery disease risk only when an unbalanced nutritional status leads to raised total plasma homocysteine levels. 相似文献
9.
Erin Tutty Chriselle Hickerton Bronwyn Terrill Belinda McClaren Rigan Tytherleigh Elaine Stackpoole Jaqueline Savard Ainsley Newson Anna Middleton Amy Nisselle Marie Cusack Melissa Adamski Clara Gaff Sylvia Metcalfe 《Health expectations》2021,24(2):670
BackgroundConsumer genomic testing for nutrition and wellness, (nutritional genomics), is becoming increasingly popular. Concurrently, health‐care practitioners (HPs) working in private practice (including doctors interested in integrative medicine, private genetic counsellors, pharmacists, dieticians, naturopaths and nutritionists) are involved as test facilitators or interpreters.ObjectiveTo explore Australian consumers’ and HPs’ experiences with nutrigenomic testing.MethodSemi‐structured in‐depth interviews were conducted using predominantly purposive sampling. The two data sets were analysed individually, then combined, using a constant comparative, thematic approach.ResultsOverall, 45 interviews were conducted with consumers (n = 18) and HPs (n = 27). Many of the consumer interviewees experienced chronic ill‐health. Nutrigenomic testing was perceived as empowering and a source of hope for answers. While most made changes to their diet/supplements post‐test, self‐reported health improvements were small. A positive relationship with their HP appeared to minimize disappointment. HPs’ adoption and views of nutrigenomic testing varied. Those enthusiastic about testing saw the possibilities it could offer. However, many felt nutrigenomic testing was not the only ‘tool’ to utilize when offering health care.DiscussionThis research highlights the important role HPs play in consumers’ experiences of nutrigenomics. The varied practice suggests relevant HPs require upskilling in this area to at least support their patients/clients, even if nutrigenomic testing is not part of their practice.Patient or public contributionAdvisory group included patient/public group representatives who informed study design; focus group participants gave feedback on the survey from which consumer interviewees were sourced. This informed the HP data set design. Interviewees from HP data set assisted with snowball sampling. 相似文献
10.
目的 研究同型半胱氨酸代谢关键酶亚甲基四氢叶酸还原酶(methylenetetrahydrofolate reductase,MTHFR)基因C677T多态性与糖尿病合并冠心病发病的关系,探讨MTHFR是否为糖尿病合并冠心病的易感基因。方法 研究对象包括105名糖尿病合并冠心病的患者(合并组)、88名单纯糖尿病患者(糖尿病组)和91名健康人。应用聚合酶链反应-限制性内切酶长度多态性方法(PCR—RFLP)检测MTHFR C677T基因多态性,同时检测血浆同型半胱氨酸(homocysteine,Hcy)、叶酸、维生素B12、各种血脂。结果 合并组与糖尿病组比,等位基因频率差异有统计学意义(Х^2=6.8,P〈0.05),合并组T等位基因的OR值为1.638(95% CI,1.082~2.479),基因型频率差异亦有统计学意义(Х^2=5.481,P〈0.05)。Logistic回归分析显示MTHFR 677携带T基因(CT+TT)的OR值为2.68(95% CI,1.233—5.824)。结论 MTHFR 677携带T基因与2型糖尿病合并冠心病发生独立相关。检测MTHFR 677位点基因特点可能为糖尿病合并冠心病的预防以及个体化治疗提供新思路、新方法。 相似文献